Palavra-chave: STEM CELL TRANSPLANTATION

TNF RADOMIZED STUDY CARDIORESPIRATORY BCR-ABL ALLOGENEIC GVHD THALIDOMIDE+DEXAMETHASONE MULTIPLE MYELOMA DEXAMETHASONE HLA-IDENTICAL ACUTE MYELOID LEUKAEMIA PERIPHERAL BLOOD AUTOLOGOUS HEMATOPOIETIC PHL (+) PHYSIOTHERAPEUTIC PROTOCOL LACOHG NON-MYELOABLATIVE VACOP-B F359V NHL CHEMOTHERAPY LEUKEMIA IN CHRONIC RISK SCORE HODGKIN S DISEASE LATIN AMERICAN COOPERATIVE ONCOHEMATOLOGY GROUP IMATINIB ERA CYTOKINE ADVANCED MULTIPLE MYELOMA HEMATOPOIETIC STEM CELLS SERUM IMMUNOGLOBULIN LEVELS NON-HODGKIN S LYMPHOMA CHRONIC MYELOGENOUS LEUKEMIA CHRONIC MYELOGENOUS LEUKEMIA IN PHASE CHRONIC EBMT GRAFT-VERSUS-DISEASE MYELOCYTIC LEUKEMIA CHRONIC MEYLOID LEUKEMIA LEPROSY MALIGNANT LYMPHOMA BRAZILIAN SINGLE ENTER PROGRESSION-FREE SURVIVAL SINGLE AUTOLOGOUS PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IL2 HLA-MATCHED HEMATOPOIETIC MALIGNANCIES GRAFT-VERSUS-HOST DISEASE GEMOH NON-HODGKIN LYMPHOMA CML MUSCLE STRENGTH AUTOLOGUS HAEMATOPOIETIC CHRONIC MYELOID LEUKEMIA HSCT FRENCH SOCIETY OF HAEMATOLOGY TNFA LESS INTENSIVE REGIMEN FOLLOWED MULTIPLE MYELOMA PATIENTS IPI NHL HIGH-DOSE SEQUENTIAL CHEMOTHERAPY RISK HEMATOPOIETIC MALIGNANCIES AEROBIC CAPACITY BLOOD AUTOLOGOUS HEMATOPOIETIC ALLOGENEIC HAEMATOPOIETIC INTERLEUKIN-2 HODGKIN LYMPHOMA MULTICENTER STUDY INTERLEUKIN-6-174CC HODGKIN´S DISEASE AAWP EBMT GROUP AHCST THALIDOMIDE IMATINIB AUTOLOGOUS CHRONIC GRAFT-VERSUS-HOST POLYMORPHISMS NON-HODGKIN´S LYMPHOMA KIR/HLA LATINAMERICAN COOPERATIVE ONCOHEMATOLOGY GROUP MYELODYSPLASTIC SYNDROME